ARCHIVES

An “insurgency” targets randomized trials, demands access to investigational drugs.

This article is from The Cancer Letter archive.

Vol. 31 No. 31 | August 5, 2005

Download PDF Visit The Full Archive

Related Articles

Study: Robotic-Assisted Surgery Offers Better Cancer Control

March 28, 2014

First Lady Helps Dedicate New MDA Facilities

October 15, 1976

FTC Cigarette Test Should Be Broadened, Cancer Panel Finds

December 16, 1994

NIH to Hold Meeting On Faculty Design

February 2, 1996

FDA Blocks Nine More INDs; Cooperative Group Chairmen, DeVita Blast “Lack of Expertise”

January 7, 1977

Emory Stops Patient Accrual After Discovering Problems In Management

June 26, 2009